Floatz logo

PRAVASTATIN

Glucose Metabolism

Kirby InstituteSmall moleculePhase 4 / ApprovedDormant
BB
67/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
53/ 100
Competitive Position
89/ 100

Competitive context

9 Active assets in the Glucose Metabolism cohort.

Asset / SponsorPhaseRating
Metformin
SINA Health Education and Welfare Trust
Phase 4BBB
ZIDOVUDINE
Kirby Institute
Phase 4BB
Empagliflozin
SINA Health Education and Welfare Trust
Phase 4BB
Exenatide
RenJi Hospital
Phase 4BB
Glargine
Federico II University
Phase 4BB

View all 28 →

Same molecule, other indications

PRAVASTATIN is also rated in:

hyperlipidemiaDormant
BBB
Indicative ·
76 / 100
View asset →
lipodystrophyDormant
BBB
Indicative ·
76 / 100
View asset →
HIV infectious diseaseDormant
BBB
Indicative ·
75 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →